Actively Recruiting

Age: 18Years +
All Genders
NCT03225820

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Led by University of Chicago · Updated on 2026-04-24

1000

Participants Needed

2

Research Sites

537 weeks

Total Duration

On this page

Sponsors

U

University of Chicago

Lead Sponsor

N

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

(a) To explore the feasibility and utility of implementing broad preemptive pharmacogenomic result delivery in the inpatient setting across multiple institutions specifically with the goal of incorporating minority-specific pharmacogenomic information; (b) To determine whether clinical outcomes for the drug warfarin are improved in African Americans through the availability of pharmacogenomics-based dosing guidance at the point-of-care.

CONDITIONS

Official Title

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients must be at least 18 years of age.
  • Patients must self-identify as African American
Not Eligible

You will not qualify if you...

  • Patients who have undergone, or are being actively considered for, liver or kidney transplantation.
  • Patients with known active or prior leukemia.
  • Inability to understand and give informed consent to participate.
  • For patients being recruited to the warfarin sub-study, those with a glomerular filtration rate or creatinine clearance <30 mL/min

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

The University of Illinois at Chicago

Chicago, Illinois, United States, 60607

Actively Recruiting

2

Northwestern University

Chicago, Illinois, United States, 60611

Not Yet Recruiting

Loading map...

Research Team

C

Cancer Clinical Trials Office

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here